Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation

Table 1 Characteristics of all 27 ABO-incompatible adult living donor liver transplantation patients

Case No.	Age/sex	Etiology	MELD	Donor age/relationship	Blood type (R/D)	Initial B-cell	Initial isoagglutinin titer IgM/IgG	Actual GRWR	Graft ischemic time1 (min)	HAIT
1	48/M	HBV + HCC	10	24/Son	B/A	16%	1:16/1:2	0.86	355	Y
2	52/F	HBV	25	24/Daughter	B/AB	13%	1:16/1:8	0.6	210	Y
3	53/M	Alcohol	33	21/Son	O/A	14%	1:64/1:256	1.14	220	Y
4	50/F	HBV + HCC	13	53/Husband	O/A	21%	1:256/1:32	0.81	203	Y
5	53/M	HCV	13	18/Daughter	B/A	22%	1:32/1:8	0.97	130	Y
6	42/M	HBV + HCC	13	39/Wife	B/A	9%	1:64/1:256	0.67	175	Y
7	65/M	HBV + HCC	10	38/Daughter	O/A	19%	1:64/1:256	1.04	128	N
8	51/M	HBV + HCC	9	23/Son	A/AB	14%	1:32/1:32	1.36	85	N
9	43/M	HBV	34	29/Wife	O/B	18%	1:32/1:32	1.02	157	N
10	49/M	HBV + HCC	7	21/Son	A/AB	21%	1:32/1:32	0.87	180	N
11	49/M	HBV + HCC	13	21/Son	O/A	18%	1:256/1:1024	0.74	201	N
12	53/M	Alcohol	13	21/Son	A/B	14%	1:64/1:512	1.07	225	N
13	59/M	HBV + HCC	12	28/Son	O/A	16%	1:64/1:512	0.93	120	N
14	47/M	HBV	14	37/Wife	O/A	29%	1:128/1:512	1.17	167	N
15	31/F	Wilson’s disease	10	29/Sister	O/A	19%	1:32/1:32	0.95	80	N
16	52/M	HBV + HCC	9	25/Daughter	O/B	9%	1:128/1:512	0.71	143	N
17	57/M	HBV + HCC	9	44/Nephew	B/A	16%	1:16/1:32	0.91	136	N
18	48/M	HBV	17	24/Daughter	O/B	32%	1:32/1:64	0.62	180	N
19	50/M	HBV + HCC	9	21/Daughter	B/A	15%	1:16/1:16	0.64	190	N
20	56/M	HBV + HCC	6	22/Son	B/AB	21%	1:16/1:16	1.14	154	N
21	45/F	HBV	13	43/Husband	O/A	6%	1:32/1:32	1.48	100	N
22	49/M	HBV + HCC	9	21/Son	O/A	11%	1:64/1:128	1.12	131	N
23	53/F	HBV + HCC	11	19/Daughter	B/AB	6%	1:8/1:2	1.21	115	N
24	43/F	HBV	22	50/Husband	B/A	10%	1:32/1:32	1.55	155	N
25	47/M	HBV + HCC	9	19/Daughter	O/A	4%	1:32/1:1024	0.89	200	N
26	52/M	HBV + HCC	10	24/Son	A/B	31%	1:32/1:32	1.01	162	N
27	35/M	HBV + HCC	6	35/Wife	O/A	20%	1:64/1:256	0.85	175	N

¹Cold ischemic time + warm ischemic time. ABO-I ALDLT: ABO-incompatible adult living donor liver transplantation; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; MELD: Model for end-stage liver disease; GRWR: Graft to recipient weight ratio; HAIT: Hepatic artery infusion therapy.